Literature DB >> 1200497

Extreme hypermagnesemia as a cause of refractory hypotension.

J P Mordes, R Swartz, R A Arky.   

Abstract

A 62-year-old woman with adequate renal function who consumed large quantities of magnesium citrate presented with lethargy and hypotension. The hypotension was refractory to all conventional therapy. Her serum magnesium was 12.5 meq/litre (normal, 1.5 to 2.5). She was found to have a perforated duodenal ulcer; peritoneal aspirate magnesium concentration was 12.2 meq/litre. Hypotension improved with intravenous calcium and peritoneal dialysis. This case shows that hypermagnesemia may be accompanied by severe refractory hypotension, and that intestinal disease may predispose to hypermagnesemia in patients ingesting large quantities of magnesium despite normal renal function. Dialysis removes excess magnesium and reverses its toxic effects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200497     DOI: 10.7326/0003-4819-83-5-657

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

Review 1.  Pharmacologic treatment of the adult hospitalized asthma patient.

Authors:  M L Kreutzer; S Louie
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  A policy for laxatives.

Authors:  D N Bateman; J M Smith
Journal:  BMJ       Date:  1988-12-03

3.  Serum and erythrocyte magnesium in critically ill patients.

Authors:  C Guérin; C Cousin; F Mignot; M Manchon; G Fournier
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

4.  High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus.

Authors:  M Sydow; T A Crozier; S Zielmann; J Radke; H Burchardi
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Hypermagnesemia-induced paralytic ileus.

Authors:  J Golzarian; H W Scott; W O Richards
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

6.  Serum magnesium, mortality and disease progression in chronic kidney disease.

Authors:  Rami Azem; Remy Daou; Elias Bassil; Eva Maria Anvari; Jonathan J Taliercio; Susana Arrigain; Jesse D Schold; Tushar Vachharajani; Joseph Nally; Georges N Na Khoul
Journal:  BMC Nephrol       Date:  2020-02-12       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.